Concert Pharmaceuticals, Inc. Return on Tangible Equity 2014-2022 | CNCE

Current and historical return on tangible equity values for Concert Pharmaceuticals, Inc. (CNCE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2022-09-30 $-0.13B $0.13B -112.89%
2022-06-30 $-0.13B $0.13B -120.19%
2022-03-31 $-0.10B $0.08B -93.43%
2021-12-31 $-0.08B $0.11B -72.32%
2021-09-30 $-0.07B $0.10B -57.39%
2021-06-30 $-0.06B $0.12B -47.58%
2021-03-31 $-0.08B $0.11B -59.57%
2020-12-31 $-0.07B $0.13B -53.14%
2020-09-30 $-0.07B $0.13B -54.65%
2020-06-30 $-0.07B $0.14B -54.05%
2020-03-31 $-0.08B $0.15B -59.84%
2019-12-31 $-0.08B $0.10B -61.90%
2019-09-30 $-0.08B $0.12B -55.34%
2019-06-30 $-0.08B $0.13B -49.53%
2019-03-31 $-0.07B $0.15B -41.48%
2018-12-31 $-0.06B $0.17B -28.80%
2018-09-30 $-0.04B $0.19B -20.20%
2018-06-30 $0.10B $0.20B 51.87%
2018-03-31 $0.10B $0.21B 62.46%
2017-12-31 $0.10B $0.20B 71.56%
2017-09-30 $0.09B $0.20B 84.56%
2017-06-30 $-0.05B $0.06B -61.06%
2017-03-31 $-0.05B $0.08B -53.99%
2016-12-31 $-0.05B $0.09B -49.26%
2016-09-30 $-0.04B $0.10B -32.82%
2016-06-30 $-0.04B $0.11B -28.93%
2016-03-31 $0.02B $0.12B 14.79%
2015-12-31 $0.02B $0.13B 19.63%
2015-09-30 $0.01B $0.13B 13.56%
2015-06-30 $0.02B $0.14B 17.29%
2015-03-31 $-0.03B $0.09B -48.40%
2014-12-31 $-0.03B $0.06B -48.30%
2014-09-30 $-0.02B $0.06B -38.10%
2014-06-30 $-0.02B $0.07B -51.70%
2014-03-31 $-0.01B $0.08B -57.14%
2013-12-31 $-0.01B $0.00B inf%